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The signal recognition particle (SRP) binds to signal
sequences when they emerge from a translating ribosome
and targets the complex of ribosome, nascent chain and
SRP to the membrane of the rough endoplasmic
reticulum (rER) allowing the co-translational
translocation of the nascent chain. By photo-crosslinking
it has been shown that the signal sequence of preprolactin
(PPL) only interacts with the methionine-rich (NI) domain
of the 54 kDa protein subunit (SRP54) of SRP. Here we
show that (i) a signal-anchor sequence is likewise
crosslinked only to the methionine-rich domain of SRP54,
(ii) free SRP54 can interact with signal sequences
independently of the other components of SRP, (iii) its
M domain suffices to perform this function, and (iv) an
essentially intact M domain is required for signal
sequence recognition. Alkylation of the N+G domain in
intact SRP54 with N-ethyl maleimide (NE), but not
after cleavage with V8 protease, prevents the binding of
a signal sequence to the M domain. This suggests a
proximity between the N+G and M domains of SRP54
and raises the possibility that the role of the N+G domain
may be to regulate the binding and/or the release of signal
sequences.
Key words: GTP binding protein/methionine-rich domain
of SRP54/photo-crosslinking/signal sequence binding/signal
recognition particle
Introduction
Three sequentially performed functions have been attributed
to the signal recognition particle (SRP): (i) Recognition of
and binding to signal sequences of proteins destined to enter
the 'secretory pathway' upon their emergence from a
translating ribosome (Walter and Lingappa, 1986), (ii) arrest
or retardation of the elongation of the nascent polypeptide
(Siegel and Walter, 1985; Wolin and Walter, 1989) until
(iii) the interaction of the complex of ribosome, nascent chain
and SRP with the docking protein (DPca) (or SRP receptor)
on the membrane of the rough endoplasmic reticulum (rER)
(Gilmore et al., 1982; Meyer et al., 1982). Upon binding
to DPo! the signal sequence is displaced from SRP in a GTP-
dependent process (Connolly and Gilmore, 1989; High
et al., 1991a), the elongation arrest is released and
translocation of the nascent polypeptide is initiated (Walter
(C) Oxford University Press
and Lingappa, 1986). SRP is subsequently released from the
membrane of the rER in a step requiring GTP hydrolysis
(Connolly et al., 1991).
SRP consists of a 7S RNA and six different proteins: a
19 kDa (SRP19) and a 54 kDa (SRP54) protein both of which
are RNA binding proteins (Lingelbach et al., 1988; Ribes
et al., 1990; Romisch et al., 1990; Zopf et al., 1990) and
two heterodimers of 9/14 kDa and 68/72 kDa respectively,
which each by themselves also bind to 7S RNA (Walter and
Blobel, 1983). The 9/14 kDa heterodimer is necessary for
the elongation arrest function of SRP (Siegel and Walter,
1985) while the 68/72 kDa heterodimer has been implicated
in the docking process (Siegel and Walter, 1988). By photo-
crosslinking (Kurzchalia et al., 1986; Krieg et al., 1986;
High et al., 1991b) and by chemical modification (Siegel
and Walter, 1988) SRP54 has been shown to be the protein
responsible for the interaction of SRP with the signal
sequences of nascent secretory and membrane proteins.
Signal sequences for rER targeting and insertion differ
widely in primary structure and have as the only common
feature an overall hydrophobic nature (von Heijne, 1988).
How SRP54 recognizes and binds to such signal sequences
is poorly understood. The investigation of this interaction
may serve as a paradigm for other signal-mediated processes.
Based on amino acid sequence homologies SRP54 has been
proposed to contain at least two domains, an N +G domain
(SRP54N +G) which contains consensus motifs for binding
GTP and a methionine-rich or M domain (SRP54M)
(Bernstein et al., 1989; Romisch et al., 1989). The
postulated domain structure is supported by the results of
analyses using limited proteolysis of SRP and identification
of the resulting fragments with peptide-specific antisera
against SRP54 (Romisch et al., 1990; Zopf et al., 1990).
These experiments located the RNA binding site of SRP54
to the M domain. Photo-crosslinking of the signal sequence
of PPL to SRP, combined with limited proteolysis,
fractionation and antibody mapping of the crosslinked
products showed that SRP54M is also the domain which
interacts with this signal sequence (Zopf et al., 1990; High
and Dobberstein, 1991). SRP54M contained in
proteolytically cleaved SRP was found still to be capable
of recognizing the signal sequence of PPL (High and
Dobberstein, 1991). However, the experiment does not
exclude that SRP54N+G was non-covalently associated with
SRP after proteolysis and therefore required for signal
sequence recognition.
Using a similar crosslinking approach to that used before
(High and Dobberstein, 1991), we here report the mapping
of the binding site on SRP54 for three signal sequences.
Lysines modified with a photo-activatable crosslinking
reagent were incorporated at different positions relative to
the hydrophobic core of these signal sequences. Thus, the
results were independent of the position of the photo-
activatable crosslinker within the nascent chain. In vitro
synthesized SRP54 was found to interact with signal
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sequences with an efficiency similar to that of SRP54 present
as part of the purified SRP complex. The effect of N-ethyl
maleimide (NEM) modification and limited proteolysis upon
the interaction between SRP54 and signal sequences was
tested. Using mutant SRP54 proteins, deleted at the NH2-
or COOH-terminus, it was possible to define the minimal
region of the protein necessary for signal sequence binding.
Results
The M domain of SRP54 interacts with different
types of signal sequences
By a photo-crosslinking approach (Krieg et al., 1986;
Kurzchalia et al., 1986) it has been shown previously (Zopf
et al., 1990; High and Dobberstein, 1991) that the cleavable
signal sequence of nascent PPL interacts with the M domain
of SRP54. A nascent chain- ribosome complex was formed
by translation of a truncated PPL mRNA in a wheat germ
cell-free translation system. [35S]methionine was included
as a label for the nascent chain. Lysyl-tRNA modified with
the UV-activatable crosslinking reagent 4-(3-trifluoromethyl-
diazarino)benzoic acid (TDBA) was incorporated into the
nascent chain as a means to identify interacting components
by photo-crosslinking. The site of crosslinking was then
mapped by limited proteolysis and immunoprecipitation with
peptide-specific antibodies.
As the arrested peptide of PPL contains lysine residues
only at positions preceding the hydrophobic core of the PPL
signal sequence (Figure 1) it remained unclear whether
lysines in other positions in this or other signal sequences
would interact with, and therefore be crosslinked to, other
parts of SRP54 (High and Dobberstein, 1991). To test this
we used the SRP-arrested translation product of the type I
membrane protein IMC-CATA27 which contains an
uncleaved signal-anchor (SA) sequence close to its
NH2-terminus (Figure 1, High et al., 199 lb). Crosslinking
reagent is incorporated in this protein exclusively COOH-
terminal of the hydrophobic core of the SA sequence
(Figure 1). Truncated IMC-CATA27 mRNA codes for the
NH2-terminal 103 amino acids of IMC-CATA27 (IMC-
CAT103A27). When the mRNA was translated in the
presence of SRP one major polypeptide of the expected
molecular mass of 11 kDa was synthesized, and upon UV
irradiation a major specific crosslinked product of 65 kDa
was seen (Figure 2, lane 1) which was absent when samples
were not irradiated (not shown). As the 65 kDa crosslinked
product could be immunoprecipitated with antisera specific
for peptides derived from SRP54 (Figure 2, lanes 3-7) but
not with a control serum (lane 2) it represents a crosslinked
product between IMC-CAT 03A27 and SRP54 (see
Figure lb for the locations of peptides used to raise the
antibodies and Romisch et al., 1990). To identify the portion
of SRP54 interacting with the SA sequence of IMC-
CAT,O3A2,'we digested the purified crosslinked complexes
of nascent chain, ribosome and SRP (Figure 2, lane 1) with
V8 protease after dissociation of ribosomes with EDTA
(lanes 8-14). These conditions had resulted in complete
cleavage of SRP54 into its M and N+G domains when
PPL86 (NH2-terminal 86 amino acids of proprolactin) was
the binding partner (High and Dobberstein, 1991). After
digestion with V8 protease the major crosslinked portion of
SRP54 had a relative molecular mass (Mr) of -21 kDa.
This was deduced by subtraction of the 8 kDa contribution
of the cleaved IMC-CAT,O3A27 from the crosslinked product
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of 29 kDa. This corresponded to an essentially intact M
domain as judged by its immunoprecipitation with the two
anti-SRP54M (lanes 13 and 14) and the lack of precipitation
with the three anti-SRP54N+G (lanes 10- 12) antisera (cf.
Figure Ib).
A minor crosslinked product migrating at -43 kDa
contained the entire M domain (precipitation by antisera 982
and 831) and contained a COOH-terminal portion of the G
domain as it was also precipitated by antiserum 981(lane 12). Note that upon cleavage by V8 protease IMC-
CAT 103A27 lost - 3 kDa of its NH2-terminus (lane 8). This
was deduced from the fact that the proteolysed nascent chain
migrated at - 8 kDa and was no longer precipitated by an
antibody raised against its NH2-terminal 30 amino acid
residues (not shown). Consistent with this cleavage is also
the slightly increased mobility of the crosslinked product
containing residual undigested SRP54 (Figure 2, lane 8).
Free SRP54 interacts with signal sequences
Since only SRP54 could be crosslinked to signal sequencesit seemed possible that it was sufficient for binding of signal
sequences. We therefore tested if SRP54 present as free
Fig. 1. (a) Outline of the nascent chains used in this study: the
synthesis of the nascent chains of preprolactin (PPL) and IMC-CAT
was arrested at amino acids 86 (PPL86) and 103 (IMC-CAT103),
respectively. Black boxes indicate the hydrophobic cores of cleavable
signal or SA sequences. The arrow on the PPL sequence points to the
site of cleavage by signal peptidase. Lysine residues ( * ) present in the
nascent chains of COOH-terminally truncated PPL (PPLI8), IMC-CAT(IMC-CATt ) and variants of IMC-CAT (IMC-CATIO3-7 and IMC-
CAT103A27 ) are found at positions 4, 9, 72 and 78 of the PPL86 and
at positions 27, 69, 72, 73, 75, 77 and 101 of IMC-CAT,03. In the
mutant IMC-CAT-27 the lysine residue at position 27 is replaced by a
glutamic acid residue. In IMC-CATP27.46 the lysine residue at position
27 is replaced by a glutamic acid residue and residue 46 is replacedby a lysine. (b) Antisera raised against peptides of SRP54 and used
for all immunoprecipitations in this study: SRP54 and its N, G(SRP54N+G) and M (SRP54M) domains are delineated by the
bordering amino acid positions (numbers in italics). The positions of
peptides used to raise anti-peptide antisera 730, 832, 981, 982 and 831(Romisch et al., 1990) are indicated by arrowheads. The approximate
position of cleavage by V8 protease is indicated by the arrow(Romisch et al., 1990).
SRP54 M domain alone binds signal sequences
protein, rather than as a component of a ribonucleoprotein
(RNP) particle, could be photo-crosslinked to PPL86
(Figure 3). SRP54 and, as a control, SRP19 were synthe-
sized in the wheat germ system in the absence of [35S]
methionine. In a separate reaction PPL86 was synthesized
in the presence of [35S]methionine and NE-4-(3-trifluoro-
methyldiazarino)benzoyl-lysyl (e-TDBA-lysyl) tRNA. The
two translation mixtures were combined and incubated,
whereupon crosslinking was induced by UV irradiation. In
a control experiment PPL86 (Mr = 9 kDa) was crosslinked
to the SRP54 subunit of added intact SRP (0.5 pmol) to yield
the expected 63 kDa product (Figure 3, lane 1; High and
Dobberstein, 1991). In the presence of in vitro synthesized
SRP54 (Figure 3, lane 5) the major crosslinked product co-
migrated with the 63 kDa of the control and was of similar
intensity (Figure 3, compare lanes 1 and 5). However, when
the translation mixture of SRPl9 was incubated with PPL86
only a less intense 61 kDa crosslinked product was seen
(Figure 3, lane 3, arrowhead). This was also observed when
wheat germ lysate which had not been programmed with
any mRNA was added (not shown). It corresponds to
crosslinked product containing the SRP54 homologue
(SRP54WG) of the endogenous wheat germ SRP (Prehn
et al., 1987). The result suggested that free SRP54 could
interact with a signal sequence.
To exclude that the in vitro synthesized SRP54 had bound
to a partially assembled wheat germ SRP, we released the
crosslinked complex from the ribosome by treatment with
puromycin and separated free SRP54 from SRP by sucrose
gradient centrifugation. We chose the centrifugation
conditions such that SRP54 would remain on top of the
gradient while SRP would move to the middle of the
gradient. When PPL86 crosslinked to SRP was thus
analysed the 63 kDa crosslinked complex was, as expected,
found in an llS particle in the middle of the gradient
(Figure 4a). In contrast, when in vitro synthesized SRP54
was used in the crosslinking assay the 63 kDa complex was
found on top of the gradient (Figure 4b). A small amount
of the 61 kDa crosslinked complex containing the
endogenous SRP54WG co-migrated with the 1iS SRP
(Figure 4b, arrow). From this experiment we conclude that
in vitro synthesized SRP54 does not assemble into an RNP
particle and is capable of recognizing the signal sequence
of PPL86 as a free protein.
Free SRP54, like its SRP-bound form, interacts with
signal sequences via its M domain
In order to test whether the interaction between the signal
sequences of PPL or IMC-CAT and free SRP54 was the
same as that with SRP-bound SRP54, we mapped the signal
sequence binding domain of free SRP54 by photo-
crosslinking and subsequent digestion with V8 protease. The
crosslinked product of PPL86 and free SRP54 (Figure 5,
lanes 1-8) was digested with V8 protease (lanes 9-16),





Fig. 2. The SA sequence of IMC-CAT103 is exclusively crosslinked to
the M domain of SRP54. The SRP- and truncation-arrested nascent
chain of IMC-CATA27 (IMC-CAT1O3A7, 11 kDa band in lane 1) was
photo-crosslinked to SRP54. The total crosslinked products are shown
after purification by centrifugation through a sucrose cushion (lane 1).
The purified material after proteolysis with 10 Ag/ml V8 protease in
the presence of 25 mM EDTA is shown in lane 8. Crosslinked
products were immunoprecipitated before (lanes 2-7) or after
proteolysis (lanes 9- 14) with the following antisera as indicated: non-
related serum (NRS), lanes 2 and 9; anti-SRP54 peptide antisera 730,
lanes 3 and 10; 832, lanes 4 and 11; 981, lanes 5 and 12; 982, lanes
6 and 13; 831, lanes 7 and 14.
Fig. 3. Cell-free synthesized SRP54 interacts with the nascent chain of
PPL8S. PPL86 was synthesized in the presence of E-TDBA-lysyl tRNA
and [ 5S]methionine. SRP (lane 1) or unlabelled cell-free translation
mixtures of mammalian SRP19 (lanes 2 and 3) or SRP54 (lanes 4 and
5) were added, and photo-crosslinking was induced by UV irradiation
(lanes 1, 3 and 5) or not (lanes 2 and 4). The UV-dependent
crosslinked products of PPL86 (9 kDa) to SRP54 contained in SRP
(lane 1) or after translation in vitro (lane 5) are indicated (63 kDa).
The 61 kDa crosslinked product of PPL86 to the endogenous wheat
germ homologue of SRP54 is indicated in lane 3 (arrowhead).
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Fig. 4. Cell-free synthesized SRP54 is not associated with an RNP
particle. Crosslinked complexes between PPL86 and SRP (a) or PPL86
and cell-free synthesized SRP54 (b) were released from the ribosome
by puromycin/high salt and centrifuged through a 5-20% sucrose
gradient. Equal fractions were collected from the top (fraction 1) to
the bottom (fraction 12) of the gradient and analysed by SDS-PAGE
and fluorography. Only the portions of the fluorograph containing the
crosslinked complexes of PPL 6 with free or SRP-contained SRP54 (63
kDa) or endogenous SRP54WG (arrow) are shown. Numbers below the
lanes indicate fraction numbers.
immunoprecipitation using five SRP54 anti-peptide antisera
(cf. Figure lb).
As expected immunoprecipitation with all five antisera of
the undigested crosslinked material yielded a product of 63
kDa (Figure 5, lanes 4-8) which was also precipitated by
a prolactin-specific antiserum (lane 2). Digestion with V8
protease did not alter the apparent Mr of PPL86 (Figure 5,
compare 9 kDa band in lane 10 with that in lane 2) although
most of the 63 kDa crosslinked product was proteolysed
(lane 10). As had been observed with SRP (High and
Dobberstein, 1991; and Figure 2) the 63 kDa complex was
digested to a major product of 30 kDa. This must be
composed of the 9 kDa PPL86 peptide and the 21 kDa M
domain of SRP54 as it was recognized only by antibodies
specific for SRP54M (Figure 5, lanes 15 and 16) but not
by those specific for SRP54N+G (Figure 5, lanes 11-14,
cf. Figure lb). A weaker crosslinked complex of 41 kDa
comprises the entire M domain and the COOH-terminal part
of the N+G domain as it was also immunoprecipitated by
both M domain-specific antisera and by antiserum 981 which
recognizes the COOH-terminal portion of the N+G domain
(Figure 5, lanes 14-16; cf. Figure lb). An experiment
using IMC-CAT103A27 as the crosslinking partner, instead
of PPL86, yielded similar crosslinking products containing
SRP54M (not shown). Thus the site of interaction of a signal
sequence with free SRP54 or with SRP-bound SRP54 is the
same.
The M domain of SRP54 alone is sufficient for
interaction with signal sequences
So far all assays that tested the binding of SRP54 to signal
sequences contained the N+G domain either as part of intact
SRP54 or present in the reaction mixture after proteolytic
cleavage (High and Dobberstein, 1991). Thus, a non-
covalent requirement for SRP54N+G during the recognition
of signal sequences could not be excluded. In order to test
if signal sequences could be recognized by SRP54M alone
we removed or inactivated SRP54N+G.
Proteolysis of SRP using V8 protease liberates
SRP54N+G from SRP54M which remains bound to the
RNP particle and can be quantitatively separated from
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SRP54N+G by absorption to DEAE - Sepharose (Romisch
et al., 1990; Zopf et al., 1990). When we tested proteolysed
SRP lacking SRP54N+G the M domain was efficiently
crosslinked to PPL86 (not shown) as previously found for
the unfractionated material (High and Dobberstein, 1991).
This suggested that the N+G domain of SRP54 was
dispensable for the interaction of SRP54M with signal
sequences.
In order to determine if SRP54M alone, i.e. in the absence
of 7S RNA and the other SRP proteins, was capable of signal
recognition we synthesized unlabelled SRP54 in vitro as
above (Figures 3 and 4) and digested it with V8 protease.
After crosslinking to PPL86, the interacting component was
identified by immunoprecipitation using antibodies
recognizing both mammalian and wheat germ SRP54N+G
(antiserum 730) or specific for the COOH-terminus of
mammalian SRP54M (antiserum 831). Figure 6, lanes 5 and
6 show that the 30 kDa proteolytic fragment of the
crosslinked complex between SRP54 and PPL86 was
recognized by antiserum 831 (Figure 6, lane 6), but not by
antiserum 730 which only immunoprecipitated the intact
endogenous SRP54WG (lane 5, arrow). Thus we conclude
that SRP54M of V8 protease digested SRP54 can interact
with the signal sequence of PPL86 while SRP54N+G
cannot.
The N+G domain was still present in the mixture after
proteolysis and could thus have assisted in signal sequence
binding. In order to inactivate this domain we made use of
the observation that intact SRP54 is inactivated by alkylation
of cysteine residues with NEM (Siegel and Walter, 1988),
and that the five cysteine residues present in mammalian
SRP54 are exclusively located in the N+G domain (Romisch
et al., 1989; Bernstein et al., 1989). Reconstitution of SRP
with NEM treated SRP54 (SRP54NEM) had rendered it
inactive in assays for elongation arrest and protein
translocation and prevented its binding to polysomes
containing PPL nascent chains (Siegel and Walter, 1988).
Consistent with these observations, we found that PPL86
could not be photo-crosslinked to NEM treated SRP (not
shown). As the M domain does not contain any cysteine
residues the NEM modified N+G domain was likely to
impair the binding of PPL86 to the M domain.
To address this possibility, cell-free synthesized SRP54
was mock treated (Figure 6, lanes 1 and 2), treated with
NEM (lanes 3 and 4), with V8 protease (lanes 5 and 6) or
with both (lanes 7 and 8) and assayed for the capacity to
bind the signal sequence of PPL86 by crosslinking. The
resulting complexes were immunoprecipitated with antisera
730 (Figure 6, lanes 1, 3, 5 and 7) and 831 (lanes 2, 4, 6
and 8). Both antisera immunoprecipitated the 63 kDa
crosslinked product of PPL86 and in vitro synthesized
mammalian SRP54 (Figure 6, lanes 1 and 2). This product
was not observed when the translation mixture of SRP54
was treated with NEM (Figure 6, lanes 3 and 4). The wheat
germ homologue of SRP54 was present in all of the
crosslinking assays in an unmodified form due to the addition
of the PPL86 translation mixture. This gave rise to the 61
kDa crosslinked complex which was immunoprecipitated
under all conditions by antiserum 730 (Figure 6, lanes 1,
3, 5 and 7, arrow). As already mentioned, digestion of
SRP54 with V8 protease resulted in a 30 kDa crosslinked
product of PPL86 and SRP54M which was immuno-
precipitated by antiserum 831 (Figure 6, lane 6) but not by
antiserum 730 (lane 5). NEM treatment of the V8 digested
SRP54 M domain alone binds signal sequences
e - .
Fig. 5. The M domain of cell-free synthesized SRP54 interacts with
the signal sequence of PPL86. Crosslinked complexes between nascent
PPL86 and cell-free synthesized SRP54 were made as described in the
legend to Figure 3 and purified by centrifugation through a sucrose
cushion. The total purified material (lane 1) was mock-digested (lanes
1 -8) or digested with 10 tg/ml V8 protease in the presence of 25
mM EDTA (lanes 9-16) and immunoprecipitated with the following
antisera: anti-prolactin (lanes 2 and 10); pre-immune serum 831 (lanes
3 and 11); the anti-SRP54 peptide antisera 730 (lanes 4 and 12); 832
(lanes 5 and 13); 981 (lanes 6 and 14); 982 (lanes 7 and 15); and 831
(lanes 8 and 16); no immunoprecipitation (lanes 1 and 9). See
Figure lb for the locations of the epitopes recognized by the
antibodies. The total and immunoprecipitated material analysed by
SDS-PAGE and fluorography is shown. The crosslinked products
between PPL86 and intact SRP54 (63 kDa) or proteolytic fragments
thereof (41 and 30 kDa) are indicated. Lanes 3-8 and 11-16 were
fluorographed five times longer than lanes 1, 2, 9 and 10.
mixture did not impair crosslinking of SRP54M (Figure 6,
lane 8), whereas it completely inhibited any crosslinking to
either intact SRP54 (lanes 3 and 4) or residual intact SRP54
present after V8 digestion (lanes 5 and 6) and visible in the
non-alkylated samples after long exposure (not shown).
Thus, the NEM modified N+G domain can only interfere
with the binding of a signal sequence if it is part of SRP54,
consistent with the N+G domain playing no direct role in
signal sequence binding.
The regions of SRP54M required for binding to 7S
RNA and signal sequences largely overlap
Besides being sufficient for interacting with signal sequences,
SRP54M alone is also capable of binding to 7S RNA in the
presence of SRP19 (Romisch et al., 1990; Zopf et al.,
1990). The binding sites have been proposed to be formed
by four amphipathic helices interacting via their hydrophobic
faces with the highly variable signal sequences (Bernstein
et al., 1989) and via their hydrophilic ones with 7S RNA
(High and Dobberstein, 1991). In order to map the binding
Fig. 6. NEM alkylation of SRP54 but not of V8 cleaved SRP54
prevents the binding of PPL86 to SRP54M. SRP54 synthesized in the
wheat germ cell-free system was mock-digested or cleaved into its
N+G and M domains by incubation with V8 protease after (lanes
1
-4) or before (lanes 5 -8) inactivation by diisopropyl
fluorophosphate, respectively. Both, SRP54 and proteolysed SRP54
were treated with NEM after (lanes 1, 2, 5 and 6) or before (lanes 3,
4, 7 and 8) the addition of dithiothreitol. After photo-crosslinking to
nascent PPL86 crosslinked products were analysed by
immunoprecipitation with antisera specific for SRP54N+G (antiserum
730, lanes 1, 3, 5 and 7) or SRP54M (antiserum 831, lanes 2, 4, 6
and 8), SDS-PAGE and fluorography. Crosslinked products of PPL86
with mammalian SRP54 (63 kDa) or SRP54M (30 kDa) and
endogenous SRP54WG (arrows) are indicated. Note that the wheat
germ extract in which PPL86 had been synthesized was not treated
with NEM.
sites for 7S RNA and signal sequences more closely we
deleted various portions of the M domain of in vitro
synthesized SRP54 and then tested the deleted proteins for
these two binding activities. Figure 7a depicts the deletions
of SRP54 and the positions of the four predicted amphipathic
helices (Bernstein et al., 1989). SRP54 truncated from its
COOH-terminus by 19, 42, 65, 90 and 140 amino acids
('54-2' to '54-6') or a segment ('54-7') comprising the
COOH-terminal 154 amino acids of SRP54M (amino acids
351 -504) were used in both tests. In addition, we tested
the in vitro synthesized M domain ('54-M', amino acids
297-504) which had been sufficient for binding to 7S
RNA-SRP19 (Romisch et al., 1990) for its capacity to
interact with signal sequences.
Binding of SRP54, and truncations thereof, to 7S RNA
was monitored by batch absorption of assembled RNP to





Fig. 7. Deletion mapping of SRP54M. (a) SRP54 and its domiiains are schematically represented as in Figure lb. The approximate position of
cleavage by V8 protease is indicated by an arrow (cf'. R6nmisch et fl., 1990). The positions ot' peptides used to raise anti-peptide antisera 730, 832.
981, 982 and 831 are indicated by arrowheads. COOH-terminal (54-2 to 54-6) and NH,-terminal (54-7 and 54-M) truncations of SRP54 (54-1) are
represented by lines with numbers in italics indicating the positions of the last or first and last amino acids. Proposed amphipathic helices (Bernstein
et al., 1989) are depicted by short lines labelled h to h3b. The binding activities to 7S RNA and signal sequences (SS) of the truncated SRP54
proteins are indicated by + and -. The + indicates inefficient binding. * BindineL to 7S RNA of in vitro synthesized SRP54M ('54-M') had been
demonstrated previously (R6rmisch et of., 1990). (b) Binding of SRP54 ('54-1') and truncated SRP54 proteins ('54-2' to '54-5') in the presence of
SRPl9 (arrow) to 7S RNA or bovine liver tRNA was tested by batch absorption of RNP particles to DEAE-Sepharose. 20% of the total input('T'), all of the DEAE-unbound material ('U') and all of the bound and eluted material ('B') were TCA precipitated and analysed by SDS-PAGE
and fluorography. Numbers on the right indicate the relative molecular imlasses of marker proteins. Incomplete cleavage resulted in the residual full-
length SRP54 observed with deletion 544 which howecer, did not compete with binding of 54-4. (c) Quantification of the relative amounts of
DEAE-unbound (U) and -bound (B) material: the original fluorograph was scanned with an LKB Ultroscan XL laser densitometer, and binding to
tRNA-SRPl9 (black bars) or 7S RNA-SRPl9 (hatched bars) was expressed as the percent of the combined bound and unbound fractions for each
SRP54 deletion (% bound = 100 B [U + B] -1, ordinate). Deletion mutants (54-2 to 54-7) of SRP54 (54-1) are indicated on the abscissa. The more
efficient binding to 7S RNA of SRP19 (mean + SD: 65.0% + 2.5%) than of SRP54 (mean SD of 54-1 to 54-4: 40.5% + 4.4%) has been
consistently observed in repeated experiments independently of the amount of protein synthesized and has been discussed previously (R6misch et al.,
1990).
et al., 1988; Romisch et al., 1990). Briefly, 7S RNA or
tRNA (as a negative control) and SRPl9 were mixed in an
estimated 16-fold molar excess with SRP54 or its deletions
and allowed to form RNPs. An aliquot of the 'total'
(Figure 7b: T) and the DEAE-'bound' (B) and -'unbound'
(U) material were analysed by SDS-PAGE and
fluorography. The results of the RNA binding assay are
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displayed in Figure 7b, quantified by scanning of the
fluorograph in Figure 7c and summarized in Figure 7a ('7S
RNA'). Binding of SRP54 to 7S RNA-SRP19 still occurred
when the COOH-terminal 65 amino acids were removed
from its M domain (Figure 7a-c, '54-2' to '54-4') but was
no longer possible when 90 or more amino acids were
deleted (Figure 7a-c, '54-5' and '54-6'). While the entire
SRP54 M domain alone binds signal sequences
Fig. 8. Photo-crosslinking of signal sequences to SRP54 and its
truncations: PPL.6 was photo-crosslinked to unlabelled cell-free
synthesized SRP54 (54-1) and its truncations (54-2 to 54-7. outlined in
Figure 7a) (lanes 3-8. 11 and 12). to endogenous components of the
wheat germ lysate (lanes I and 9) and to SRP (lanes 2 and 10).
Crosslinked complexes were immunoprecipitated with anti-peptide
antisera recognizing an epitope in the NH,-terminal (982. lanes 1 -81
or the COOH-terminal region (lanes 9- 12) ot SRP54M and specific
for the mammalian SRP54. The products wxere analysed hb
SDS-PAGE and fluorography. Positions of molecular maiL.ss imiark-ers
are indicated on the right.
M domain ('54-M') had been found to bind to 7S
RNA-SRPl9 (R6misch et al.. 1990). binding no longer was
possible when the 53 NH,-terminal amino acids of
SRP54M were removed (Figure 7a and c. '54-7').
The same truncated SRP54 proteins were also tested in
crosslinking assays (in the absence of 7S RNA and SRP19)
for their abilities to interact with the signal sequences of
PPL86 (Figure 8), IMC-CAT103 and IMC-CAT103<A27,46 (not
shown). Crosslinked products were immunoprecipitated with
the appropriate antisera, i.e. antiserum 982 for SRP54-1 to
54-6 (lanes 3-8) and antiserum 831 for SRP54- 1 and
SRP54-7 (lanes 11 and 12). Since neither antiserum
precipitates the endogenous wheat germ SRP54 homologue
no crosslinked complexes were observed when only wheat
germ lysate (WG) was added (Figure 8, lanes 1 and 9). Both
antisera precipitated SRP54 which had been added to the
crosslinking reactions as a positive control and was either
part of purified SRP ('SRP', Figure 8. lanes 2 and 10) or
derived from translation in vitro ('54-1', Figure 8. lanes 3
and 1 1). Of the COOH-terminally truncated proteins. only
SRP54-2 interacted with the signal sequences of PPL86
(Figure 8, lane 4), IMC-CATt) or IMC-CAT0 ;'2746 (not
shown). Since in SRP54-2 only the COOH-terminal 19
amino acids had been removed from SRP54 only a small
shift in Mr of -2 kDa can be seen (Figure 8, cf. lanes 3
and 4; see also Figure 7b). All further COOH-terminal
truncations (54-3 to 54-6) abolished the capability to interact
with either of the three signal sequences tested. The minor
crosslinked product seen in lane 6 of Figure 8 (63 kDa) is
that of incompletely truncated full-length SRP54 (cf.
Figure 7b '54-4').
The signal sequence binding capacity of in vitro
synthesized SRP54M ('54-M', Romisch et al., 1990) was
found to be low (not shown) while the COOH-terminal 154
amino acids of SRP54 ('54-7T) were incapable of binding
any of the signal sequences (not shown and Figure 8,
lane 12). Since the M domain derived from in vitro
synthesized SRP54 by V8 proteolysis showed efficient signal
sequence binding (Figure 6) this suggests that in vitro
synthesized M domains may not be able to fold into the
correct conformation for optimal signal sequence binding.
Discussion
Photo-crosslinking was combined with limited proteolysis
and mapping with site-specific antibodies or deletion
mutagenesis to characterize the interaction between signal
sequences and SRP54. Previously, this interaction had only
been investigated for the cleavable signal sequence of
preprolactin. and the M domain of SRP54 was the only
detectable site of interaction (Zopf et al., 1990; High and
Dobberstein, 1991). Since uncleaved SA sequences, which
can mediate the membrane insertion of type I and type II
membrane proteins, also interact with SRP54 (High et al.,
1991 b) it was of interest to know if they also contacted the
same domain of SRP54. For the type I SA sequence of IMC-
CAT we show here that it also interacts with the M domain
of SRP54. Thus, both a cleavable signal sequence and an
uncleaved SA sequence are only in contact with SRP54M
and not with SRP54N+G.
In PPL the lysine residues are found only NH,-terminal
of the hydrophobic core of the signal sequence. By contrast,
in IMC-CAT 27 the lysine residues from which crosslinking
can occur are only found COOH-terminal of the hydrophobic
core of the SA sequence. Thus, crosslinking from these
molecules can occur from either side of the hydrophobic core
of the signal sequence. As both proteins were crosslinked
to the M domain but not to the N+G domain, it is likely
that over their entire length signal sequences are only in
contact with the M domain of SRP54.
Since the only component of SRP detected to interact with
signal sequences was SRP54. it was conceivable that free
SRP54 alone was sufficient to perform this function. This
was indeed found to be the case since proteins bearing a
cleavable signal sequence or a SA sequence were efficiently
crosslinked to ini vitro synthesized free SRP54. SRP54
synthesized in this cell-free system was not part of a RNP
particle. This was clearly demonstrated by sucrose gradient
analysis which showed that in vitro synthesized SRP54 did
not migrate as an 1IS RNP particle but as a free protein.
The site of interaction of signal sequences with free SRP54
was found to be the same as that with SRP-bound SRP54
since again only SRP54M was found in contact with the
signal sequences of PPL or IMC-CAT. The crosslinking of
signal sequences to free SRP54 and SRP-bound SRP54 was
of roughly similar efficiency, since comparable molar
quantities of in *vitro synthesized and particle-bound SRP54
(as tested by immunoblotting; not shown) resulted in
crosslinked products of similar intensities.
SRP54M retained in the RNP particle and even in its free
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form was found to interact with signal sequences. The
presence of SRP54N+G was not required for this
interaction, although alkylation of the N+G domain of intact
SRP54 inhibited signal sequence binding. In a previous
study, alkylation of SRP54 with NEM (SRP54NEM)
followed by its reconstitution into SRP rendered this particle
unable to promote elongation arrest of PPL or to bind to
a complex of ribosome and nascent chain (Siegel and Walter,
1988). This was interpreted as SRP54NEM being unable to
recognize signal sequences. By photo-crosslinking we show
that this is indeed the case, and that free SRP54NEM unlike
its unmodified form is unable to interact with signal
sequences. The physical separation of SRP54N+G from
SRP54M by cleavage with V8 protease prior to alkylation
allowed the subsequent cross-linking of SRP54M to PPL86.
In canine SRP54 only the N+G domain can be alkylated
by NEM since all cysteine residues, the targets for
modification by NEM, are found in this domain and none
are present in the M domain.
What could be the mechanism by which the NEM
modified N+G domain inhibits the binding of a signal
sequence to SRP54M? At least two scenarios can explain
this finding. (i) The N+G domain could be close to the signal
sequence binding site of the M domain such that alkylation
could then block the entry of a signal sequence into its
binding site on SRP54M by steric hindrance. (ii)
Alternatively, alkylation of any one cysteine residue could
interfere with a GTP-related function of the N+G domain
which contains consensus motifs typical for GTPases(Bernstein et al., 1989; Romisch et al., 1989). In vivo this
domain may function to regulate the recognition and/or
binding of signal sequences to the M domain by
conformational changes induced by its GTP/GDP binding
state. In either case, the removal of SRP54N+G by
proteolysis would allow SRP54M to resume its function.
Fine mapping of the signal binding site on SRP54 using
COOH-terminally deleted SRP54 proteins revealed that
nearly the entire M domain was required for binding to three
different signal sequences. Since the binding of a signal
sequence was deduced from its ability to be crosslinked we
used several nascent chains with lysine residues at various
positions. This made it unlikely that a truncated M domain
capable of signal sequence binding could not be crosslinked
to the nascent chain and could therefore escape detection.
For all signal sequences tested only the 19 most COOH-
terminal amino acid residues of SRP54 could be deleted
without destroying its signal sequence binding function. For
binding to 7S RNA-SRPl9 a slightly larger fragment
comprising the 65 most COOH-terminal amino acids of
SRP54 was found dispensable. SRP54M created by cleavage
ofSRP54 with V8 protease efficiently bound to both 7S RNA(R6misch et al., 1990; Zopf et al., 1990) and to signal
sequences. Based on secondary structure predictions the
primary amino acid sequence of SRP54M has been proposed
to form four amphipathic helices the hydrophobic faces of
which might constitute a binding pocket for signal sequences
(Bernstein et al., 1989). It was furthermore proposed that
the hydrophilic faces of the helices could interact with 7S
RNA (High and Dobberstein, 1991). This implies that the
RNA and signal sequence binding functions of SRP54 would
overlap on SRP54M. Alternatively, the RNA and signal
sequence binding functions could be performed by separate
sub-domains. Our results are consistent with the former view
namely that largely overlapping regions of SRP54M are
essential for both RNA and signal sequence binding.
Our finding that free, i.e. RNP-unbound SRP54 can
interact with signal sequences raises the possibility that thefunction of SRP may require the sequential assembly anddisassembly of SRP54 with the rest of the RNP complex.
The possibility that a free form of SRP54 has a role in SRP-




T7 RNA polymerase, RNase H, V8 protease, Klenow and restriction
enzymes were from Boehringer Mannheim GmbH (Mannheim, Germany).Taq polymerase was from Perkin Elmer Cetus Co. (Emeryville, CA).[35S]Methionine was from Amersham Buchler GmbH (Braunschweig,Germany). Cycloheximide, emetine, 7-methyl-guanosine 5'-monophosphate
and puromycin were supplied by Sigma Chemical Co. (St Louis, MO).
DEAE-Sepharose CL 6B was from Pharmacia. 4-(3-trifluoromethyl-diazarino) benzoic acid (TDBA) was a gift from Dr Josef Brunner, Swiss
Federal Institute of Technology, Zurich, Switzerland.
SRP54 deletions
Deletion mutants 54-2 to 54-4 were made by annealing complementary
oligonucleotides in large molar excess to the in vitro transcript of SRP54
at the position to be cleaved and incubating it in translation buffer with RNase
H (0.5 U/25 itl) for 15 min at 37°C. As deduced from the positions of
the complementary oligonucleotides the SRP54 proteins, 54-2, 54-3 and54-4, were arrested at the COOH-termini of amino acids 484, 462 and 442,
respectively. Deletions 54-5 and 54-6 were constructed on the cDNA level
by substituting a fragment 3' of the unique BglII site in pSRP54-1 (Romisch
et al., 1989) with corresponding PCR fragments coding for stop codons
at amino acid positions 415 and 363, respectively. Deletion mutant 54-7
was constructed by removing the cDNA sequence coding for SRP54N +G
up to the BglII site in pSRP54-1 (Romisch er al., 1989). The first codon
for methionine following the BglII site (amino acid position 351) was very
efficiently used as the initiation site in the wheat germ translation systemyielding a 17 kDa protein (not shown).
Transcription and translation
Transcription of pSRP54- 1 and deletion constructs thereof with T7
polymerase was performed as recommended by the manufacturer. For thephoto-crosslinking assays truncated mRNA coding for the NH,-terminal
regions of preprolactin (PPL86) and the artificial type I membrane signal
anchor protein IMC-CAT and its variants (Figure 1) was prepared aspreviously described (High et al., 1991b). Translations in the wheat germ
cell-free translation system were carried out as previously described (Stueber
et al., 1984).
Photo-crosslinking analysis
For photo-crosslinking translation was performed as described by Stueber
et al. (1984) in the presence of 3.75 pmol E-TDBA-Lys-tRNA per 25 izlof translation mixture. The E-TDBA-Lys-tRNA was prepared as describedby Wiedmann et al. (1987) except that the modified Lys-tRNA was not
submitted to benzoyl DEAE-cellulose chromatography. Cell-free
translations of PPL86 and IMC-CAT,03 were pulsed (Krieg et al., 1986)by addition of 7-methylguanosine 5'-monophosphate to a final concentration
of 2 mM after 10 min of incubation. Translations were continued for a further5 min and then cycloheximide added to 2 mM to prevent further chain
elongation. Translation of truncated nmiRNA yields nascent chains whichdue to the lack of a stop codon largely remain bound to the ribosomes.
When purified SRP was used it was present during the translation at,
or added after the completion of translation to, a final concentration of 25
nM. When unlabelled SRP proteins made by cell-free translation wereincluded they were added at an equal volume of translation mixture to that
of the completed synthesis of PPL86 or IMC-CAT103.After the addition of SRP or cell-free translation products to the nascent
chain - ribosome complex the mixture was incubated at 25°C for 5 min
and then chilled on ice. Subsequent irradiation of the samples on ice was
as previously described (High et al., 199 lb). After irradiation the samples
were TCA precipitated for direct analysis or immunoprecipitated under
denaturing conditions using peptide-specific antisera (Romisch et al., 1990).
When crosslinked products or ribosome-nascent chain complexes were
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purified this was performed by centrifugation through a high salt/sucrose
cushion as previously described (High et al., 199 la).
Sucrose gradient analysis
Crosslinked complexes were formed between PPL86 and SRP or in vitro
synthesized SRP54 as described above except that emetine was added to
2 mM instead of cycloheximide to inhibit further chain elongation. The
crosslinked complexes were released from the ribosome by the addition of
puromycin to 0.3 mM and the adjustment of KOAc to 0.4 M followed by
an incubation at 25°C for 10 min. Samples were centrifuged for 20 h in
an SW40 rotor at 39000 r.p.m. and 4°C through a 5-20% sucrose gradient
containing 0.5 M KOAc, 20 mM HEPES-KOH pH 7.5 and 5 mM
Mg(OAc)2. Fractions of 1 ml were collected from the top and TCA-
acetone precipitated prior to analysis by SDS-PAGE and fluorography.
Proteolysis of SRP and in vitro synthesized SRP54 using V8
protease
SRP and cell-free synthesized SRP54 were digested with 25 Ag/ml V8
protease (protease Glu-X from Stapkvlococcus aureus, strain V8) as described
(High and Dobberstein, 1990) with inactivation of the protease using
diisopropyl fluorophosphate before or after the incubation. After the treatment
of cell-free synthesized SRP54 with V8 protease the pH was adjusted to
7.0 by the addition of 100 mM HEPES. N-ethyl maleimide was added to
10 mM and quenched by the addition of 15 mM dithiothreitol before or
after an incubation for 30 min at 250 C.
Fractionation of proteolysed SRP using DEAE - Sepharose
After treatment of 12.5 pmol of SRP with V8 protease (Romisch et al.,
1990; High and Dobberstein, 1991) the products were allowed to bind 50
1l of DEAE-Sepharose slurry (25 A1 beads suspended in 25 tl1 TMK buffer:
50 mM TEA pH 7.5, 5 mM Mg(OAc)2 and 250 mM KOAc). After
binding the beads were pelleted and the supernatant containing unbound
material removed. The beads were washed three times in 1 ml of TMK
buffer. The bound material was eluted in 100 141 of 50 mM TEA pH 7.5,
5 mM Mg(OAc)2 and 600 mM KOAc for 20 min. The elution was repeated
and the supernatants were combined. The eluted material was tested for
signal sequence binding. Analysis of proteolysed and DEAE-fractionated
products by Western blotting was as previously described (Romisch et al.,
1990).
RNA binding assay
Binding of SRP proteins to 7S RNA was monitored by batch absorption
of assembled SRP sub-particles to DEAE as described previously (Romisch
et al., 1990; Lingelbach et al., 1988).
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